cefminox has been researched along with moxalactam in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (75.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kanamori, M; Kirikae, T; Kitao, T; Miyoshi-Akiyama, T; Morita, K; Okazaki, M; Sekiguchi, J; Watanabe, N | 1 |
Ando, A; Kikuchi, S; Minato, K | 1 |
Goi, H; Inouye, S; Kitasato, I | 1 |
Goi, H; Hara, T; Inouye, S; Ishii, T; Kazuno, Y; Watanabe, T | 1 |
Kumamoto, Y; Miyamoto, S; Takatsuka, K; Tamiya, T | 2 |
Date, H; Goi, H; Hara, T; Ishii, T; Jinzaki, M; Kasai, T; Matsugami, A; Miyauchi, K; Shindo, H; Watanabe, T | 1 |
Hara, K; Kanda, T; Saito, A; Sawatari, K; Toro, J | 1 |
8 other study(ies) available for cefminox and moxalactam
Article | Year |
---|---|
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Citrobacter freundii; Conjugation, Genetic; DNA Primers; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli K12; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
[Acquired coagulopathy caused by administration of parenteral broad-spectrum antibiotics].
Topics: Aged; Aged, 80 and over; Biomarkers; Cephalosporins; Cephamycins; Hemorrhagic Disorders; Humans; Male; Moxalactam; Parenteral Nutrition, Total; Protein Precursors; Prothrombin; Vitamin K Deficiency | 1991 |
Bacteriolytic combination effect of cefminox and piperacillin evaluated by turbidimetry.
Topics: Bacteria; Cephamycins; Methionine; Microbial Sensitivity Tests; Moxalactam; Nephelometry and Turbidimetry; Piperacillin | 1989 |
[Antibacterial activity of cefminox in human urine].
Topics: Bacteria; Cefotaxime; Cephamycins; Humans; In Vitro Techniques; Moxalactam; Urine | 1988 |
Effects of MT-141, a new cephamycin antibiotic, on acute urinary tract infections.
Topics: Adult; Aged; Cefotaxime; Cephamycins; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Urinary Tract Infections | 1985 |
Comparison of rapid bacteriological response to MT-141 and latamoxef in complicated urinary tract infections.
Topics: Adult; Cephamycins; Humans; Microbial Sensitivity Tests; Moxalactam; Urinary Tract Infections | 1985 |
[Antibacterial activity of MT-141 against anaerobic bacteria].
Topics: Animals; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Cefmetazole; Cephamycins; Clostridium Infections; Clostridium perfringens; Drug Resistance, Microbial; Mice; Moxalactam | 1984 |
New beta-lactamase-resistant cephem treatment of guinea pigs infected with Legionella pneumophila.
Topics: Animals; Cefotaxime; Cefotiam; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Erythromycin; Guinea Pigs; Legionnaires' Disease; Moxalactam | 1983 |